Zaarah Herbals’ Rasayan Churan, Gurmar Powder, Vasaka Powder, and Bhringraj Powder recalled in four states due to potential ...
President Donald Trump is scheduled Thursday to welcome NATO Secretary General Mark Rutte to the White House. The pair are ...
Jay Bhattacharya, nominee for National Institutes of Health director, and FDA pick Marty Makary clear key Senate committee.
President Donald Trump's nominee to lead the Food and Drug Administration (FDA) Dr. Marty Makary passed a key committee vote on Thursday morning.
Recently selected Food and Drug Administration chief lawyer, Hilary K. Perkins, has resigned from the job, according to a ...
Dyne Therapeutics’ DYNE-101 shows positive results in phase 1/2 ACHIEVE study. Read why DYN stock may rise with FDA approval and a $2.78B market opportunity.
In the Boston area, three months into the new year, the mood in the biotech industry has soured and the outlook has clouded.
"Receiving the FDA's clearance to proceed with our Phase 2 clinical trial for TPST-1495, our second clinical program, in FAP marks an important step forward in developing new treatment options for ...
2hon MSN
A clot-busting drug recently approved to treat acute ischemic strokes (AIS) that can be delivered quickly works as well as a ...
2hOpinion
Michael Lewis on Heather Stone of the Food and Drug Administration.
Treatments for dry eye disease, neuroendocrine tumors, chronic spontaneous urticaria, Barth syndrome, and migraine are under review.
FLORHAM PARK, N.J., March 13, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback